PortfoliosLab logoPortfoliosLab logo
PFE vs. XLV
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

PFE vs. XLV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Pfizer Inc. (PFE) and State Street Health Care Select Sector SPDR ETF (XLV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PFE achieves a 4.10% return, which is significantly higher than XLV's -2.23% return. Over the past 10 years, PFE has underperformed XLV with an annualized return of 1.96%, while XLV has yielded a comparatively higher 9.86% annualized return.


PFE

1D
-0.52%
1M
-3.17%
YTD
4.10%
6M
2.82%
1Y
11.94%
3Y*
-7.59%
5Y*
-3.66%
10Y*
1.96%

XLV

1D
0.88%
1M
0.56%
YTD
-2.23%
6M
-2.55%
1Y
15.69%
3Y*
6.13%
5Y*
5.50%
10Y*
9.86%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PFE vs. XLV - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PFE
Pfizer Inc.
4.10%0.65%-2.22%-41.26%-10.41%66.70%3.07%-6.91%24.82%15.90%
XLV
State Street Health Care Select Sector SPDR ETF
-2.23%14.50%2.47%2.07%-2.08%26.04%13.30%20.45%6.28%21.77%

Correlation

The correlation between PFE and XLV is 0.56, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.56

Correlation (3Y)
Calculated over the trailing 3-year period

0.52

Correlation (5Y)
Calculated over the trailing 5-year period

0.56

Correlation (10Y)
Calculated over the trailing 10-year period

0.62

Correlation (All Time)
Calculated using the full available price history since Dec 22, 1998

0.61

The correlation between PFE and XLV has been stable across timeframes, ranging from 0.52 to 0.62 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PFE vs. XLV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PFE
PFE Risk / Return Rank: 5858
Overall Rank
PFE Sharpe Ratio Rank: 6060
Sharpe Ratio Rank
PFE Sortino Ratio Rank: 5454
Sortino Ratio Rank
PFE Omega Ratio Rank: 5252
Omega Ratio Rank
PFE Calmar Ratio Rank: 6464
Calmar Ratio Rank
PFE Martin Ratio Rank: 6262
Martin Ratio Rank

XLV
XLV Risk / Return Rank: 3030
Overall Rank
XLV Sharpe Ratio Rank: 3030
Sharpe Ratio Rank
XLV Sortino Ratio Rank: 3232
Sortino Ratio Rank
XLV Omega Ratio Rank: 2828
Omega Ratio Rank
XLV Calmar Ratio Rank: 3131
Calmar Ratio Rank
XLV Martin Ratio Rank: 2727
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PFE vs. XLV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Pfizer Inc. (PFE) and State Street Health Care Select Sector SPDR ETF (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PFEXLVDifference
Sharpe ratioReturn per unit of total volatility

-0.55

Sortino ratioReturn per unit of downside risk

-0.75

Omega ratioGain probability vs. loss probability

1.11

1.19

-0.08

Calmar ratioReturn relative to maximum drawdown

1.05

1.51

-0.46

Martin ratioReturn relative to average drawdown

2.06

3.56

-1.50

PFE vs. XLV - Sharpe Ratio Comparison

The current PFE Sharpe Ratio is 0.50, which is lower than the XLV Sharpe Ratio of 1.05. The chart below compares the historical Sharpe Ratios of PFE and XLV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

PFE vs. XLV - Drawdown Comparison

The maximum PFE drawdown since its inception was -69.24%, which is greater than XLV's maximum drawdown of -39.17%. Use the drawdown chart below to compare losses from any high point for PFE and XLV.


Loading charts...

Drawdown Indicators


PFEXLVDifference

Max Drawdown

Largest peak-to-trough decline

-69.24%

-39.17%

-30.07%

Max Drawdown (1Y)

Largest decline over 1 year

-11.47%

-10.47%

-1.00%

Max Drawdown (3Y)

Largest decline over 3 years

-37.69%

-17.11%

-20.58%

Max Drawdown (5Y)

Largest decline over 5 years

-58.96%

-17.11%

-41.85%

Max Drawdown (10Y)

Largest decline over 10 years

-58.96%

-28.40%

-30.56%

Current Drawdown

Current decline from peak

-48.02%

-5.53%

-42.49%

Average Drawdown

Average peak-to-trough decline

-22.91%

-7.12%

-15.79%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.80%

4.42%

+1.38%

Volatility

PFE vs. XLV - Volatility Comparison

Pfizer Inc. (PFE) has a higher volatility of 5.40% compared to State Street Health Care Select Sector SPDR ETF (XLV) at 5.14%. This indicates that PFE's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PFEXLVDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.40%

5.14%

+0.26%

Volatility (6M)

Calculated over the trailing 6-month period

14.21%

10.58%

+3.63%

Volatility (1Y)

Calculated over the trailing 1-year period

23.93%

15.06%

+8.87%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.50%

14.76%

+10.74%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.91%

16.59%

+7.32%

Dividends

PFE vs. XLV - Dividend Comparison

PFE's dividend yield for the trailing twelve months is around 6.86%, more than XLV's 2.11% yield.


PositionTTM20252024202320222021202020192018201720162015
PFE
Pfizer Inc.
6.86%6.91%6.33%5.70%3.12%2.64%3.92%3.68%3.12%3.53%3.69%3.47%
XLV
State Street Health Care Select Sector SPDR ETF
2.11%1.60%1.67%1.59%1.47%1.33%1.49%2.17%1.57%1.47%1.60%1.43%

Frequently Asked Questions


PFE and XLV have a correlation of 0.56, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PFE has higher volatility (5.40%) compared to XLV (5.14%). In terms of maximum drawdown, PFE dropped -69.24% vs XLV's -39.17%.

XLV currently has the higher Sharpe Ratio (1.05 vs 0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PFE and XLV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer